CircRNAs and cancer: Biomarkers and master regulators. (October 2019)

• Record Type: Journal Article
• Authors: Arnaiz, Esther; Sole, Carla; Manterola, Lorea; Iparraguirre, Leire; Otaegui, David; Lawrie, Charles H.
• Is Part Of: Seminars in cancer biology. Volume 58(2019)
• Page Start: 90
• Page End: 99
• Publication Date: 2019-10
• Subjects: circRNA -- Biomarkers -- Liquid biopsies -- Non-coding RNA; Cancer -- Periodicals; Neoplasms -- Periodicals; Review Literature; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.semcancer.2018.12.002
• Languages: English
• ISSNs: 1044-579X

Abstract

Abstract: Circular RNAs (circRNAs) are a novel class of regulatory RNAs that despite being relatively abundant have only recently begun to be explored. There are many thousands of genes that appear capable of producing circRNAs, however the function of all but a handful remain to be determined. What is emerging about these highly conserved molecules is that they play important roles in biology and cancer biology in particular. The most explored function of circRNAs is as master regulators of gene expression that act to sequester or ´sponge´ other gene expression regulators, in particular miRNAs. They have also been demonstrated to function via direct modulation of transcription, and by interfering with splicing mechanisms. Although generally expressed in low abundance when compared to their linear counterparts, they are often expressed in a tissue- and developmental stage- specific manner. Coupled with their remarkable resistance to RNAse activity due to a covalent closed cyclic structure, circRNAs show great promise as novel biomarkers of cancer and other diseases. In this review we consider the current state of knowledge regarding these molecules, their synthesis, function, and association with cancer. We will also review some of the challenges that remain to be resolved if this emerging class of RNAs are really to become useful in the clinic.